Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience | Zendy

Eudocia Q. Lee | Zendy; Wendy Selig | Zendy; Clair Meehan | Zendy; Jeffrey Bacha | Zendy; Amy Barone | Zendy; Erik Bloomquist | Zendy; Susan M. Chang | Zendy; John de Groot | Zendy; Evanthia Galanis | Zendy; Islam Hassan | Zendy; Chitkala Kalidas | Zendy; Mustafa Khasraw | Zendy; Joseph C. Kvedar | Zendy; Andrew B. Lassman | Zendy; Vinay K. Puduvalli | Zendy; Solmaz Sahebjam | Zendy; Lee H. Schwamm | Zendy; Sharon Ovnat Tamir | Zendy; Mary Welch | Zendy; W.K. Alfred Yung | Zendy; Gelareh Zadeh | Zendy; David Arons | Zendy; Patrick Y. Wen | Zendy

Open Access

Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience

Author(s) -

Eudocia Q. Lee,

Wendy Selig,

Clair Meehan,

Jeffrey Bacha,

Amy Barone,

Erik Bloomquist,

Susan M. Chang,

John de Groot,

Evanthia Galanis,

Islam Hassan,

Chitkala Kalidas,

Mustafa Khasraw,

Joseph C. Kvedar,

Andrew B. Lassman,

Vinay K. Puduvalli,

Solmaz Sahebjam,

Lee H. Schwamm,

Sharon Ovnat Tamir,

Mary Welch,

W.K. Alfred Yung,

Gelareh Zadeh,

David Arons,

Patrick Y. Wen

Publication year - 2021

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/noab082

Subject(s) - clinical trial , covid-19 , food and drug administration , brain tumor , medicine , medical education , psychiatry , pharmacology , disease , infectious disease (medical specialty)

On July 24, 2020, a workshop sponsored by the National Brain Tumor Society was held on innovating brain tumor clinical trials based on lessons learned from the COVID-19 experience. Various stakeholders from the brain tumor community participated including the US Food and Drug Administration (FDA), academic and community clinicians, researchers, industry, clinical research organizations, patients and patient advocates, and representatives from the Society for Neuro-Oncology and the National Cancer Institute. This report summarizes the workshop and proposes ways to incorporate lessons learned from COVID-19 to brain tumor clinical trials including the increased use of telemedicine and decentralized trial models as opportunities for practical innovation with potential long-term impact on clinical trial design and implementation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research